cilostazol has been researched along with Cardiac Arrest, Sudden in 4 studies
Excerpt | Relevance | Reference |
---|---|---|
"Cilostazol was discontinued 2 days before replacement because of its antiplatelet effects." | 5.40 | Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes. ( Ayabe, R; Ebata, Y; Fukui, A; Nakagawa, M; Okada, N; Shinohara, T; Takahashi, N; Yufu, K, 2014) |
"Cilostazol was discontinued 2 days before replacement because of its antiplatelet effects." | 1.40 | Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes. ( Ayabe, R; Ebata, Y; Fukui, A; Nakagawa, M; Okada, N; Shinohara, T; Takahashi, N; Yufu, K, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shinohara, T | 1 |
Ebata, Y | 1 |
Ayabe, R | 1 |
Fukui, A | 1 |
Okada, N | 1 |
Yufu, K | 1 |
Nakagawa, M | 1 |
Takahashi, N | 1 |
Patocskai, B | 1 |
Barajas-Martinez, H | 1 |
Hu, D | 1 |
Gurabi, Z | 1 |
Koncz, I | 1 |
Antzelevitch, C | 1 |
Hong, MK | 1 |
Mintz, GS | 1 |
Lee, CW | 1 |
Kim, YH | 1 |
Lee, SW | 1 |
Song, JM | 1 |
Han, KH | 1 |
Kang, DH | 1 |
Song, JK | 1 |
Kim, JJ | 1 |
Park, SW | 1 |
Park, SJ | 1 |
Saniabadi, AR | 1 |
Takeich, S | 1 |
Yukawa, N | 1 |
Nakajima, Y | 1 |
Umemura, K | 1 |
Nakashima, M | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Revascularization With Paclitaxel-coated Balloon Angioplasty Versus Drug-eluting Stenting in Acute Myocardial Infarction - a Randomized Controlled Trial.[NCT02219802] | 120 participants (Anticipated) | Interventional | 2014-08-31 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
4 other studies available for cilostazol and Cardiac Arrest, Sudden
Article | Year |
---|---|
Combination therapy of cilostazol and bepridil suppresses recurrent ventricular fibrillation related to J-wave syndromes.
Topics: Adult; Anti-Arrhythmia Agents; Bepridil; Cilostazol; Death, Sudden, Cardiac; Dose-Response Relations | 2014 |
Cellular and ionic mechanisms underlying the effects of cilostazol, milrinone, and isoproterenol to suppress arrhythmogenesis in an experimental model of early repolarization syndrome.
Topics: Action Potentials; Animals; Cardiac Electrophysiology; Cardiovascular Agents; Cilostazol; Death, Sud | 2016 |
Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
Topics: Aged; Aspirin; Atherectomy, Coronary; Catheterization; Cilostazol; Combined Modality Therapy; Corona | 2004 |
Apo E4/3-rich remnant lipoproteins and platelet aggregation: a case report.
Topics: 2-Chloroadenosine; Adenosine Diphosphate; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; A | 1998 |